|
|
||||||||
Original Research |
1 Department of Radiology, University of Wisconsin School of Medicine and Public
Health, E3/311 Clinical Science Center, 600 Highland Ave., Madison, WI
53792-3252.
2 Department of Radiology, Uniformed Services University of the Health Sciences,
Bethesda, MD.
3 Gastroenterology and Digestive Endoscopy Unit, "Nuovo Regina
Margherita" Hospital, Rome, Italy.
4 Department of Radiological Sciences, University "Polo Pontino,"
Rome, Italy.
OBJECTIVE. CT colonography (CTC) is a recommended test for colorectal cancer (CRC) screening according to the updated 2008 American Cancer Society guidelines. CTC can also accurately detect abdominal aortic aneurysm (AAA). This collaborative gastroenterology–radiology project evaluated the cost-effectiveness and clinical efficacy of CTC in the Medicare population.
MATERIALS AND METHODS. A computerized Markov model simulated the
development of CRC and AAA in a hypothetical cohort of 100,000 U.S. adults
65 years old. Screening with CTC at 5- and 10-year intervals using a 6-mm
size threshold for polypectomy was compared with primary optical colonoscopy
screening every 10 years and with no screening. Base case costs for CTC and
optical colonoscopy were $674 and $795, respectively. The costs of the imaging
workup for extracolonic findings at CTC were also included.
RESULTS. CTC resulted in 7,786 and 7,027 life-years gained at 5- and 10-year intervals, respectively, compared with 6,032 life-years gained with 10-year optical colonoscopy. The increase in overall efficacy with CTC was primarily due to prevention of AAA rupture because CRC prevention and CRC detection rates were similar for CTC and optical colonoscopy. All three strategies were highly cost-effective compared with no screening, with an incremental cost-effectiveness ratio (ICER) of $6,088, $1,251, and $1,104 per life-year gained for 5-year CTC, 10-year CTC, and 10-year optical colonoscopy strategies, respectively. The ICER of 5-year CTC and 10-year CTC versus optical colonoscopy was $23,234 and $2,144 per life-year gained, respectively.
CONCLUSION. Because of its ability to simultaneously screen for both CRC and AAA, CTC is a highly cost-effective and clinically efficacious screening strategy for the Medicare population.
Keywords: aortic aneurysm colorectal cancer cost-effectiveness analysis CT colonography screening
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
C. M. Rutter, K. M. Kuntz, A. G. Zauber, and the Colorectal Cancer Modeling Group in the Cancer Extracolonic Findings From CTC: Balancing Risks and Benefits Am. J. Roentgenol., November 1, 2009; 193(5): W470 - W470. [Full Text] [PDF] |
||||
![]() |
P. J. Pickhardt, C. Hassan, and D. H. Kim Reply Am. J. Roentgenol., November 1, 2009; 193(5): W471 - W471. [Full Text] [PDF] |
||||
![]() |
B. D. Cash, S. S. Dhruva, and R. F. Redberg CMS's Landmark Decision on CT Colonography N. Engl. J. Med., September 24, 2009; 361(13): 1316 - 1317. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |